SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-020219
Filing Date
2022-08-12
Accepted
2022-08-11 20:20:21
Documents
57
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dffn20220630_10q.htm   iXBRL 10-Q 748010
2 EXHIBIT 31.1 ex_409471.htm EX-31.1 10357
3 EXHIBIT 31.2 ex_409472.htm EX-31.2 10391
4 EXHIBIT 32.1 ex_409473.htm EX-32.1 4794
5 EXHIBIT 32.2 ex_409474.htm EX-32.2 5143
11 dffn20220630_10qimg001.jpg GRAPHIC 3726
  Complete submission text file 0001437749-22-020219.txt   3836890

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dffn-20220630.xsd EX-101.SCH 38941
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dffn-20220630_cal.xml EX-101.CAL 21485
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20220630_def.xml EX-101.DEF 260688
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20220630_lab.xml EX-101.LAB 240163
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20220630_pre.xml EX-101.PRE 282910
51 EXTRACTED XBRL INSTANCE DOCUMENT dffn20220630_10q_htm.xml XML 523751
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 221157480
SIC: 2834 Pharmaceutical Preparations